John de Groot

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.4K citations

Medicine, Immunology, Oncology +17

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Nicholas Butowski, Howard Colman, John de Groot et al. · Neuro-Oncology · 2015 · 580 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

John de Groot, Gregory N. Fuller, Ashok J. Kumar et al. · Neuro-Oncology · 2010 · 505 citations · Full text

Medicine, Oncology, Pharmacology +14

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef et al. · Journal of Clinical Oncology · 2023 · 462 citations · Full text

Medicine, Oncology, Radiology +17

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

Funda Meric‐Bernstam, Lauren Brusco, Kenna Shaw et al. · Journal of Clinical Oncology · 2015 · 430 citations · Full text

Medicine, Genetics, Oncology +17